Quantitative analysis of β-blockers in pharmaceutical preparations by capillary electrophoresis

Drug Development and Industrial Pharmacy

Volumn 31, Issue 2, 2005, Pages 209-214

  Coragem, Ana Cecília ^a   Briguenti, ^a   Pierina, ^a   Bonato, Sueli ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

blockers; Capillary electrophoresis; Pharmaceutical preparations

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PINDOLOL; PROPRANOLOL DERIVATIVE;

ACCURACY; ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; DRUG DETERMINATION; DRUG SYNTHESIS; MEDICAL LITERATURE; RELIABILITY; TABLET; VALIDATION PROCESS;

ADRENERGIC BETA-ANTAGONISTS; ELECTROPHORESIS, CAPILLARY; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS;

EID: 14644388215     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-200047809     Document Type: Article

References (20)

1. Altria, K. D., & Elder, D. (2004). Overview of the status and applications of capillary electrophoresis to the analysis of small molecules. Journal of Chromatography, A, 1023:1-14.
2. Altria, K. D., Kelly, M. A., & Clark, B. J. (1998a). Current applications in the analysis of pharmaceuticals by capillary electrophoresis - I. Trends in Analytical Chemistry, 17 (4):204-214.
3. Altria, K. D., Kelly, M. A., & Clark, B. J. (1998b). Current applications in the analysis of pharmaceuticals by capillary electrophoresis - II. Trends in Analytical Chemistry, 17 (4):214-226.
4. Bonato, P. S., & Paias, F. O. (2004). Enantioselective analysis of omeprazole in pharmaceutical formulations by chiral high-performance liquid chromatography and capillary electrophoresis. Journal of the Brazilian Chemical Society, 15 (2):318-323.
5. (1999). British Pharmacopeia. Her Majesty's Stationery Office, London.
6. Fabre, H., & Altria, K. D. (2001). Key points for validating CE methods, particularly in pharmaceutical analysis. LC GC, 19:498-505.
7. Hardman, J. G., Goodman-Gilman, A., & Limbird, L. E. (1996). The Pharmacological Basis of Therapeutics (9th ed.). New York: McGraw-Hill.
8. Hassan, S. S. M., Abou-Sekkina, M. M., El-Ries, M. A., & Wassel, A. A. (2003). Polymeric matrix membrane sensors for sensitive potentiometric determination of some β-blockers in pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis, 32:175-180.
9. ICH Guidance for Industry (2004). Q2B Validation of Analytical Procedures: Methodology. http://www.fda.gov/cber/guidelines.htm. Accessed Oct. 2004.
10. Issaq, H. J. (2002). Thirty-five years of capillary electrophoresis: advances and perspectives. Journal of Liquid Chromatography and Related Technologies, 25 (8):1153-1170.
11. Khalil, S., & Borham, N. (2000). Indirect atomic absorption spectrometric determination of pindolol, propranolol and levamisole hydrochlorides based on formation of ion-associates with ammonium reineckate and sodium cobaltinitrite. Journal of Pharmaceutical and Biomedical Analysis, 22:235-240.
12. Khalil, S., & El-Rabiehi, M. M. (2000). Indirect atomic absorption spectrometric determination of pindolol, propranolol and levamisole hydrochlorides based on fonnation of ion associates with manganese thiocyanate and potassium ferricyanide. Journal of Pharmaceutical and Biomedical Analysis, 22:7-12.
13. Nguyen, N. T., & Siegler, R. W. (1996). Capillary electrophoresis of cardiovascular drugs. Journal of Chromatography, A, 735:123-150.
14. Park, Y.-J., Lee, D. W., & Lee, W.-Y. (2002). Determination of β-blockers in pharmaceutical preparations and human urine by high-performance liquid chromatography with tris(2,2′-bipyridyl) ruthenium(II) electrogenerated chemiluminescence detection. Analytica Chimica Acta, 471:51-59.
15. Prado, M. S. A., Steppe, M., Tavares, M. F. M., Kedor-Hackmann, E. R. M., & Santoro, M. I. R. M. (2002). Comparison between capillary electrophoresis and liquid chromatography for the determination of diclofenac sodium in a pharmaceutical tablet. Journal of AOAC International, 85 (2):333-340.
16. Prado, M. S. A., Kedor-Hackmann, E. R. M., Santoro, M. I. R. M., Pinto, T. J. A., & Tavares, M. F. M. (2004). Capillary electrophoretic method for determination of protease inhibitor indinavir sulfate used in human immunodeficiency virus therapy. Journal of Pharmaceutical and Biomedical Analysis, 34 (2):441-450.
17. Shabir, G. A. (2003). Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, US Pharmacopeia and the International Conference on Harmonization. Journal of Chromatography, A, 987:57-66.
18. Shafaati, A., & Clark, B. J. (1996). Development and validation of a capillary zone electrophoretic method for the determination of atenolol in presence of its related substances in bulk and tablet dosage form. Journal of Pharmaceutical and Biomedical Analysis, 14:1547-1554.
19. Steppe, M., Prado, M. S. A., Tavares, M. F. M., Pinto, T. J. A., Kedor-Hackmann, E. R. M., & Santoro, M. I. R. M. (2003). Comparison of micellar electrokinetic chromatography, liquid chromatography, and microbiologic assay for analysis of cephalexin in oral suspensions. Journal of AOAC International, 86 (4):707-713.
20. (1999). US Pharmacopeia, 24. United States Pharmacopeal Convention, Rockville, MD.